Phase-transition engineered semi-metallic Cu3PdN for photothermal-enhanced cuproptosis-induced cancer therapy

In-situ activation of cuproptosis shows considerable promise in cancer therapy. However, its efficacy is often hindered by the accumulation of copper ions and limitations of the activation strategy. Herein, a novel copper-palladium nitride (Cu3PdN)-modified injectable hydrogel with enhanced photothe...

Full description

Saved in:
Bibliographic Details
Main Authors: Yao Gao, Guangru Li, Shuoxun Chen, Weijie Yu, Shuanglong Yi, Yu Chen, Luodan Yu
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Materials Today Bio
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590006425004971
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850235273285206016
author Yao Gao
Guangru Li
Shuoxun Chen
Weijie Yu
Shuanglong Yi
Yu Chen
Luodan Yu
author_facet Yao Gao
Guangru Li
Shuoxun Chen
Weijie Yu
Shuanglong Yi
Yu Chen
Luodan Yu
author_sort Yao Gao
collection DOAJ
description In-situ activation of cuproptosis shows considerable promise in cancer therapy. However, its efficacy is often hindered by the accumulation of copper ions and limitations of the activation strategy. Herein, a novel copper-palladium nitride (Cu3PdN)-modified injectable hydrogel with enhanced photothermal conversion efficiency was designed to improve copper accumulation at tumor sites and achieve photothermia-enhanced cuproptosis. A phase transition from Cu3N to Pd-doped Cu3PdN was achieved, transforming the material from a semiconductor to a semi-metal with a reduced band gap. This modification endowed Cu3PdN with full-spectrum absorption and enhanced photothermal conversion efficiency. Coupled with the abundant copper content, Cu3PdN nanoparticles hold great potential for photothermal-enhanced, in-situ cuproptosis-based cancer therapy. The Cu3PdN system demonstrates stimulus-responsive Cu(I) ions release and Fenton-like activity, promoting the generation of reactive oxygen species, mitochondrial dysfunction, and the oligomerization of dihydrolipoamide S-acetyltransferase, which together trigger cuproptosis. Overall, this study provides a promising approach for utilizing metal nitrides to induce photothermal-enhanced cuproptosis in tumor therapy.
format Article
id doaj-art-a43f53334e2c433b96e9b7267e3837f5
institution OA Journals
issn 2590-0064
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series Materials Today Bio
spelling doaj-art-a43f53334e2c433b96e9b7267e3837f52025-08-20T02:02:19ZengElsevierMaterials Today Bio2590-00642025-06-013210192710.1016/j.mtbio.2025.101927Phase-transition engineered semi-metallic Cu3PdN for photothermal-enhanced cuproptosis-induced cancer therapyYao Gao0Guangru Li1Shuoxun Chen2Weijie Yu3Shuanglong Yi4Yu Chen5Luodan Yu6Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, PR ChinaMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, PR ChinaMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, PR ChinaMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, PR ChinaDepartment of Radiology, Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, PR China; Corresponding author.Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, PR China; Corresponding author.Department of Radiology, Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, PR China; Corresponding author.In-situ activation of cuproptosis shows considerable promise in cancer therapy. However, its efficacy is often hindered by the accumulation of copper ions and limitations of the activation strategy. Herein, a novel copper-palladium nitride (Cu3PdN)-modified injectable hydrogel with enhanced photothermal conversion efficiency was designed to improve copper accumulation at tumor sites and achieve photothermia-enhanced cuproptosis. A phase transition from Cu3N to Pd-doped Cu3PdN was achieved, transforming the material from a semiconductor to a semi-metal with a reduced band gap. This modification endowed Cu3PdN with full-spectrum absorption and enhanced photothermal conversion efficiency. Coupled with the abundant copper content, Cu3PdN nanoparticles hold great potential for photothermal-enhanced, in-situ cuproptosis-based cancer therapy. The Cu3PdN system demonstrates stimulus-responsive Cu(I) ions release and Fenton-like activity, promoting the generation of reactive oxygen species, mitochondrial dysfunction, and the oligomerization of dihydrolipoamide S-acetyltransferase, which together trigger cuproptosis. Overall, this study provides a promising approach for utilizing metal nitrides to induce photothermal-enhanced cuproptosis in tumor therapy.http://www.sciencedirect.com/science/article/pii/S2590006425004971CuproptosisMetal nitridesPhotothermal materialsTumor therapy
spellingShingle Yao Gao
Guangru Li
Shuoxun Chen
Weijie Yu
Shuanglong Yi
Yu Chen
Luodan Yu
Phase-transition engineered semi-metallic Cu3PdN for photothermal-enhanced cuproptosis-induced cancer therapy
Materials Today Bio
Cuproptosis
Metal nitrides
Photothermal materials
Tumor therapy
title Phase-transition engineered semi-metallic Cu3PdN for photothermal-enhanced cuproptosis-induced cancer therapy
title_full Phase-transition engineered semi-metallic Cu3PdN for photothermal-enhanced cuproptosis-induced cancer therapy
title_fullStr Phase-transition engineered semi-metallic Cu3PdN for photothermal-enhanced cuproptosis-induced cancer therapy
title_full_unstemmed Phase-transition engineered semi-metallic Cu3PdN for photothermal-enhanced cuproptosis-induced cancer therapy
title_short Phase-transition engineered semi-metallic Cu3PdN for photothermal-enhanced cuproptosis-induced cancer therapy
title_sort phase transition engineered semi metallic cu3pdn for photothermal enhanced cuproptosis induced cancer therapy
topic Cuproptosis
Metal nitrides
Photothermal materials
Tumor therapy
url http://www.sciencedirect.com/science/article/pii/S2590006425004971
work_keys_str_mv AT yaogao phasetransitionengineeredsemimetalliccu3pdnforphotothermalenhancedcuproptosisinducedcancertherapy
AT guangruli phasetransitionengineeredsemimetalliccu3pdnforphotothermalenhancedcuproptosisinducedcancertherapy
AT shuoxunchen phasetransitionengineeredsemimetalliccu3pdnforphotothermalenhancedcuproptosisinducedcancertherapy
AT weijieyu phasetransitionengineeredsemimetalliccu3pdnforphotothermalenhancedcuproptosisinducedcancertherapy
AT shuanglongyi phasetransitionengineeredsemimetalliccu3pdnforphotothermalenhancedcuproptosisinducedcancertherapy
AT yuchen phasetransitionengineeredsemimetalliccu3pdnforphotothermalenhancedcuproptosisinducedcancertherapy
AT luodanyu phasetransitionengineeredsemimetalliccu3pdnforphotothermalenhancedcuproptosisinducedcancertherapy